BlackRock Institutional Trust’s ImmunityBio IBRX Stock Holding History

BlackRock Institutional Trust’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.99M	Buy	348,105 +19,236	+6%	+$128K	﹤0.01%	3056
2016 Q3	$2.56M	Buy	328,869 +84,330	+34%	+$630K	﹤0.01%	2955
2016 Q2	$1.52M	Buy	244,539 +57,321	+31%	+$445K	﹤0.01%	3149
2016 Q1	$1.54M	Sell	187,218 -1,667	-0.9%	-$15.7K	﹤0.01%	3147
2015 Q4	$3.27M	Buy	188,885 +17,832	+10%	+$265K	﹤0.01%	2911
2015 Q3	$1.96M	Buy	+171,053	New	+$3.73M	﹤0.01%	3127

Other funds holding IBRX

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Institutional Trust's IBRX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its ImmunityBio (IBRX) stake by 5.8% in Q4 2016, buying an estimated $128K and bringing the position to 348,105 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3056.

BlackRock Institutional Trust first reported a position in IBRX in Q3 2015 and has held it in 6 quarters since. The position peaked at $3.27M in Q4 2015. 68 funds tracked by Wall St. Rank hold IBRX as of Q4 2016.

BlackRock Institutional Trust held 348,105 shares of ImmunityBio worth $1.99M as of Q4 2016.
BlackRock Institutional Trust bought 19,236 ImmunityBio shares in Q4 2016, an estimated $128K.
ImmunityBio made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3056 holding.
BlackRock Institutional Trust first reported a position in ImmunityBio in Q3 2015 and has held it in 6 quarters since.
BlackRock Institutional Trust's ImmunityBio position peaked at $3.27M in Q4 2015.
68 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.